Suppr超能文献

关于维生素D类似物选择性作用的机制

On the mechanisms for the selective action of vitamin D analogs.

作者信息

Dusso A S, Negrea L, Gunawardhana S, Lopez-Hilker S, Finch J, Mori T, Nishii Y, Slatopolsky E, Brown A J

机构信息

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

出版信息

Endocrinology. 1991 Apr;128(4):1687-92. doi: 10.1210/endo-128-4-1687.

Abstract

A variety of analogs of 1,25-(OH)2D3 with less calcemic activity and lower receptor binding affinity than 1,25-(OH)2D3 have been developed. However, these compounds have equal or greater ability to differentiate leukemia cells and psoriatic fibroblasts and to suppress PTH synthesis and secretion. The mechanism for this selectivity has not been elucidated. Because the lower potency of ergocalciferol compared to cholecalciferol in preventing or curing rickets in chicks was associated with a lower affinity of the avian vitamin D binding protein (DBP) for vitamin D2, we tested five analogs with low calcemic activity including 22-oxa-1,25-(OH)2D3 (OCT), MC903, 1,25-(OH)2-16 ene-23-yne D3, 1,25-(OH)2-26,27 dihomo-22-ene-D3, and 1,25-(OH)2-24-trihomo-22-ene-D3 for their affinity for rat serum DBP. All analogs had a low affinity for DBP, ranging from 50-3000 times less than that of 1,25-(OH)2D3. OCT also bound with low affinity to dog and human serum DBP. We tested with OCT the possible consequences of its low affinity for serum DBP. One of the functions of DBP is to prolong the lifetime of 1,25-(OH)2D3 in circulation. Quantification of the metabolic clearance rate (MCR) of OCT in 8 normal dogs using a single bolus injection technique showed that OCT was cleared at a rate of 48.2 +/- 7.5 ml/min, approximately 6-7 times more rapidly than 1,25-(OH)2D3 (6.8 +/- 0.4 ml/min). The estimated half-life of OCT in the circulation was 2.5 +/- 0.3 h compared to 7.0 +/- 0.6; n = 7 for 1,25-(OH)2D3. As our primary interest is the potential of OCT in treating the secondary hyperparathyroidism of CRF, we also measured the MCR of OCT in 5/6 nephrectomized dogs. Uremia does not affect the rate of clearance of OCT from the circulation (MCR: 56.8 +/- 4.5; t1/2 = 2.1 +/- 0.2 n = 4). Despite its shorter half-life, OCT suppressed PTH secretion in vivo in uremic dogs. The effects of low binding to DBP on the percentage uremic dogs. The effects of low binding to DBP on the percentage of free sterol were determined using an ultrafiltration procedure. We compared the proportion of free (unbound) OCT and 1,25-(OH)2D3 in 0.1% BSA-PBS with concentrations of human serum ranging from 0-25%. The proportion of OCT in the free form was significantly higher than that of 1,25-(OH)2D3 for every serum concentration tested. The physiological relevance of a higher percentage of free OCT was tested in normal human macrophages.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

已研发出多种1,25-(OH)₂D₃类似物,其血钙活性低于1,25-(OH)₂D₃,与受体的结合亲和力也较低。然而,这些化合物在分化白血病细胞和银屑病成纤维细胞以及抑制甲状旁腺激素(PTH)合成与分泌方面具有相同或更强的能力。这种选择性的机制尚未阐明。由于与胆钙化醇相比,麦角钙化醇在预防或治愈雏鸡佝偻病方面效力较低,这与禽类维生素D结合蛋白(DBP)对维生素D₂的亲和力较低有关,因此我们测试了五种低血钙活性的类似物,包括22-氧杂-1,25-(OH)₂D₃(OCT)、MC903、1,25-(OH)₂-16-烯-23-炔-D₃、1,25-(OH)₂-26,27-二高-22-烯-D₃和1,25-(OH)₂-24-三高-22-烯-D₃对大鼠血清DBP的亲和力。所有类似物对DBP的亲和力都很低,比1,25-(OH)₂D₃低50至3000倍。OCT与犬和人血清DBP的结合亲和力也很低。我们用OCT测试了其对血清DBP低亲和力可能产生的后果。DBP的功能之一是延长1,25-(OH)₂D₃在循环中的半衰期。采用单次大剂量注射技术对8只正常犬体内OCT的代谢清除率(MCR)进行定量分析,结果显示OCT的清除速率为48.2±7.5 ml/min,约为1,25-(OH)₂D₃(6.8±0.4 ml/min)的6至7倍。OCT在循环中的估计半衰期为2.5±0.3小时,而1,25-(OH)₂D₃为7.0±0.6小时;1,25-(OH)₂D₃的n = 7。由于我们主要关注OCT治疗慢性肾衰竭继发性甲状旁腺功能亢进的潜力,因此我们也测量了5/6肾切除犬体内OCT的MCR。尿毒症不影响OCT从循环中的清除速率(MCR:56.8±4.5;t₁/₂ = 2.1±0.2,n = 4)。尽管OCT半衰期较短,但它在体内可抑制尿毒症犬的PTH分泌。采用超滤法测定DBP低结合对尿毒症犬游离甾醇百分比的影响。我们比较了在含0.1%牛血清白蛋白(BSA)的磷酸盐缓冲液(PBS)中,人血清浓度为0至25%时游离(未结合)OCT和1,25-(OH)₂D₃的比例。对于所测试的每种血清浓度,游离形式的OCT比例均显著高于1,25-(OH)₂D₃。在正常人类巨噬细胞中测试了较高百分比的游离OCT的生理相关性。(摘要截选至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验